BioTech Breakthrough’s Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry “We believe EsoGuard, the first and only commercially available diagnostic ...
EsoGuard 2.0 incorporates advanced molecular techniques and leverages improvements in sample DNA yields and processes to enhance assay performance and lower costs The results of the analytical ...
Study demonstrates outstanding clinical utility including an exceptionally high 85% patient compliance with referral to confirmatory upper endoscopy following EsoGuard esophageal precancer testing ...
LONG BEACH, Calif. (KABC) -- Many people experience occasional acid reflux. But if you have it all the time, it could lead to a very serious condition and in some cases, cancer. Now, there's a new ...
(WISH) — A new non-invasive test called EsoGuard offers hope for early detection of esophageal cancer, a disease affecting over 22,000 Americans each year. Esophageal cancer has a grim prognosis, with ...
FULLERTON, Calif. (KABC) -- The latest findings reveal esophageal cancer rates are up across the board. Many factors can raise your risk, including your line of work. A recently FDA-approved, ...
FORT WORTH, Texas — Over the last two weeks, Fort Worth firefighters have been taking a few minutes out of their shift to screen for esophageal cancer using a new test. "When this was something that ...
NEW YORK--(BUSINESS WIRE)--Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned ...
NEW YORK--(BUSINESS WIRE)--Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results